Inventor
HALPERIN JOSE A
US22 patents
⚠️ This page may combine multiple inventors who share the name “HALPERIN JOSE A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HARVARD COLLEGE
9 patentsUS7737172B2Jun 15, 2010
3-3-di-substituted-oxindoles as inhibitors of translation initiation
HARVARD COLLEGE19 citations91
US11161910B2Nov 2, 2021
Glycated CD59 peptides, their preparation, and uses thereof
HARVARD COLLEGE2 citations73
US6066319AMay 23, 2000
Drug delivery using terminal complement components
HARVARD COLLEGE11 citations64
US11891448B2Feb 6, 2024
Glycated CD59 peptides, their preparation, and uses thereof
HARVARD COLLEGE0 citations62
US8044089B2Oct 25, 2011
3-3-di-substituted-oxindoles as inhibitors of translation initiation
HARVARD COLLEGE1 citations61
US7846962B2Dec 7, 2010
3-3-di-substituted-oxindoles as inhibitors of translation initiation
HARVARD COLLEGE1 citations61
US8354440B2Jan 15, 2013
3-3-di-substituted-oxindoles as inhibitors of translation initiation
HARVARD COLLEGE1 citations60
US10309973B2Jun 4, 2019
Surrogates of post-translationally modified proteins and uses thereof
HARVARD COLLEGE0 citations52
US9952200B2Apr 24, 2018
Cell based quality control bioassays for nutriceutical and medicinal products
HARVARD COLLEGE0 citations41
HALPERIN JOSE A
6 patentsUS8298779B2Oct 30, 2012
Methods, products and treatments for diabetes
HALPERIN JOSE A10 citations92
US9068006B2Jun 30, 2015
Glycated CD59 peptides, their preparation, and uses thereof
HALPERIN JOSE A6 citations83
US8404451B2Mar 26, 2013
Mass spectrometric methods and products
HALPERIN JOSE A7 citations83
US8268879B2Sep 18, 2012
3-3-di-substituted-oxindoles as inhibitors of translation initiation
HALPERIN JOSE A4 citations71
US8088816B2Jan 3, 2012
3-3-di-substituted-oxindoles as inhibitors of translation initiation
HALPERIN JOSE A2 citations60
US8999646B2Apr 7, 2015
Quality control bioassays for nutriceutical and medicinal products
HALPERIN JOSE A1 citations50